Daily E-cigarette Use and the Surge in JUUL Sales: 2017-2019.

Autor:	Pierce JP; Herbert Wertheim School of Public Health and Human Longevity Science.; Moores Cancer Center., Zhang J; Herbert Wertheim School of Public Health and Human Longevity Science., Crotty Alexander LE; School of Medicine, Division of Pulmonary Critical Care & Sleep.; Section of Pulmonary Critical Care, Veteran's Administration San Diego Healthcare System, San Diego, California., Leas EC; Herbert Wertheim School of Public Health and Human Longevity Science., Kealey S; Moores Cancer Center., White MM; Moores Cancer Center., Strong DR; Herbert Wertheim School of Public Health and Human Longevity Science.; Moores Cancer Center., Trinidad DR; Herbert Wertheim School of Public Health and Human Longevity Science., McMenamin SB; Herbert Wertheim School of Public Health and Human Longevity Science., Chen R; Herbert Wertheim School of Public Health and Human Longevity Science., Benmarhnia T; Scripps Institution of Oceanography, University of California San Diego, San Diego, California., Messer K; Herbert Wertheim School of Public Health and Human Longevity Science.; Moores Cancer Center.
Jazyk:	angličtina
Zdroj:	Pediatrics [Pediatrics] 2022 Jun 01; Vol. 149 (6).
DOI:	10.1542/peds.2021-055379
Abstrakt:	Objectives: To identify how the 2017 rapid surge in sales of JUUL e-cigarettes affected usage among US youth and young adults. Methods: Annual surveys in the Population Assessment of Tobacco and Health Study assess tobacco use by product and brand among the US population. We identified 2 cohorts aged 14 to 34 years, 1 with baseline survey in 2014 before the rapid surge of JUUL and the other in 2017 as the surge in JUUL sales was occurring. For 5 age groups, we compared 2-year incidence of first tobacco use and of new-onset daily tobacco use by product, and report levels of dependence. Results: Sociodemographic variables and rates of experimentation with any tobacco product were similar between cohorts. Among baseline nondaily tobacco users, only those aged 14 to 17 years had an increase in the 2-year incidence of new daily tobacco use (2014 cohort = 4.8%, 95% confidence interval 4.3, 5.5 vs 2017 cohort = 6.3%, 95% confidence interval 5.8-7.0) to rates approaching those in the 1990s. In 2019, three-quarters of new daily tobacco users aged 14 to 17 vaped daily and had e-cigarette dependence scores similar to daily cigarette smokers and older adult e-cigarette vapers. We estimate that about 600 000 Americans aged <21 years used JUUL products daily in 2019, a rate 2.5 times those aged 25 to 34 years. Conclusions: The surge in US JUUL sales was associated with a sharp rise in daily e-cigarette vaping and daily tobacco use among US youth, not young adults. (Copyright © 2022 by the American Academy of Pediatrics.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu